Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
The Journal of Allergy and Clinical Immunology: In Practice | May 09, 2019
Multimorbidity in asthma, allergic conditions and COPD increase disease severity, drug use and costs: The Finnish pharmacy survey
International Archives of Allergy and Immunology | Apr 25, 2019
Tiotropium is efficacious in 6- to 17-year-olds with asthma, independent of T2 phenotype
The Journal of Allergy and Clinical Immunology: In Practice | Apr 24, 2019
Most read this week